Biocryst医药(BCRX)
6.24 0.07 1.1345%
| 今开：6.12 | 昨收：6.17 |
| 最高：6.25 | 最低：5.99 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.287793029E9 |
Biocryst医药的热门讨论
丰硕创投04-19 16:20
$Biocryst医药(BCRX)$ 2024年1月5日，BioCryst公司宣布用于治疗HAE的血浆激肽释放酶抑制剂ORLADEYO®(berotralstat)的2023年初步销售额为3.25亿美元，符合23Q3时给出的销售指引，并给出2024年销售指引为3.8-4亿美元。查看全文
持股变动声明
Biocryst医药(BCRX)05-15 19:15
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015367 Size: 4 KB 网页链接查看全文
季度财报
Biocryst医药(BCRX)05-08 04:15
$Biocryst医药(BCRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-021069 Act: 34 Size: 7 MB 网页链接查看全文
持股变动声明
Biocryst医药(BCRX)05-22 19:35
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-016190 Size: 4 KB 网页链接查看全文
持股变动声明
Biocryst医药(BCRX)06-15 04:35
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737 Size: 6 KB 网页链接查看全文
其他
Biocryst医药(BCRX)04-26 04:35
$Biocryst医药(BCRX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022074 Act: 34 Size: 1 MB 网页链接查看全文
股东委托书协议
Biocryst医药(BCRX)04-26 04:25
$Biocryst医药(BCRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-018175 Act: 34 Size: 3 MB 网页链接查看全文
持股变动声明
Biocryst医药(BCRX)05-15 19:15
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015363 Size: 4 KB 网页链接查看全文
持股变动声明
Biocryst医药(BCRX)05-15 19:25
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015369 Size: 4 KB 网页链接查看全文
当期报告
Biocryst医药(BCRX)06-14 04:25
$Biocryst医药(BCRX)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001171843-24-003430 Act: 34 Size: 372 KB 网页链接查看全文
Biocryst医药的最新讨论
优美股异常期权2017-02-25 04:45
$Biocryst医药(BCRX)$ BCRX异常看涨期权买入：纽约时间15:41:48， 1545个Apr到期，看涨到12.0的期权被买入，合约价为$0.50,总共花费$ 77k，当时股价是5.49 Ref。查看全文
赢在USA2016-03-07 22:35
$Biocryst医药(BCRX)$ Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference查看全文
![[鼓鼓掌]](http://js.xueqiu.com/ugc/images/face/emoji_03_applaud.png?v=1 "[鼓鼓掌]"){kind=small}
kwansyu2-c2016-02-13 19:11
字母五行：
竖直线，五行属木：I、H、K、L、
尖顶交叉形，五行属火：A、M、N、V、
横线平顶，五行属土：E、F、T、
圆弧形带钩，五行属金：O、C、D、G、J、R、
波浪起伏形，五行属水：B、Q、S、U、W
今年猴年, 是火猴年, 上半年为火旺，下半年为水旺。
一到猴年，一看$Bio...查看全文
Biocryst医药的新闻
美股异动 | WSB散户宣布“生物科技战”，遭沽空医药股盘前普涨，BioCryst制药(BCRX.US)涨超10%
智通财经APP获悉，2月2日（周二）美股盘前，WSB散户宣布“生物科技战”，受散户追捧的生物技术股票普涨。截至发稿，BioCryst制药(BCRX.US)涨10.57%，诺瓦瓦克斯医药 (NVAX.US)涨4.36%、德纳维制药(DVAX.US)涨10.03%、Inovio Pharmaceuti... 网页链接
Reddit大军向空头宣布“生物科技战” 若干被沽空生物科技股大涨
Reddit大军向空头宣布“生物科技战”，若干被沽空生物科技股大幅上涨。Biocryst医药（BCRX）股价上涨逾40%，刷新2015年10月份以来盘中高位至11.98美元。 Reddit的WallStreetBets论坛上，有用户称该制药公司是“市场上被低... 网页链接
Biocryst医药的公告
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018846 Size: 5 KB 网页链接
证券出售报告
$Biocryst医药(BCRX)$ 144 Report of proposed sale of securities Accession Number: 0001971857-24-000419 Act: 33 Size: 4 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018715 Size: 9 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018720 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018725 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018728 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018733 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018705 Size: 6 KB 网页链接
持股变动声明
$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018708 Size: 7 KB 网页链接